PERCEPTIVE ADVISORS LLC Q4 2021 Filing
Filed February 14, 2022
Portfolio Value
$6.5B
Holdings
145
Report Date
Q4 2021
Filing Type
13F-HR
All Holdings (145 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 101 | —1LIFE HEALTHCARE INC | 532,350 | $9.4B | 144.32% | |
| 102 | TCE2CELLDEX THERAPEUTICS INC NEW | 229,807 | $8.9B | 137.02% | |
| 103 | LEGNLEGEND BIOTECH CORP | 189,100 | $8.8B | 136.00% | |
| 104 | NBTXNANOBIOTIX SA | 1,059,800 | $8.6B | 132.45% | |
| 105 | —EQRX INC | 1,250,000 | $8.5B | 131.54% | |
| 106 | MDGLMADRIGAL PHARMACEUTICALS INC | 86,400 | $7.3B | 112.98% | |
| 107 | SGHTSIGHT SCIENCES INC | 390,000 | $6.9B | 105.73% | |
| 108 | CNCEEURCONCERT PHARMACEUTICALS INC | 2,150,641 | $6.8B | 104.53% | |
| 109 | —POINT BIOPHARMA GLOBAL INC | 1,193,995 | $6.7B | 103.17% | |
| 110 | AORTCRYOLIFE INC | 326,318 | $6.6B | 102.47% | |
| 111 | ACCDEURACCOLADE INC | 228,774 | $6.0B | 93.05% | |
| 112 | CLOVCLOVER HEALTH INVESTMENTS CO | 1,500,000 | $5.6B | 86.10% | |
| 113 | PRVBUSDPROVENTION BIO INC | 948,481 | $5.3B | 82.24% | |
| 114 | —ONCORUS INC | 999,812 | $5.3B | 81.30% | |
| 115 | FULCFULCRUM THERAPEUTICS INC | 294,118 | $5.2B | 80.28% | |
| 116 | NVNOENVVENO MEDICAL CORPORATION | 781,615 | $5.2B | 79.47% | |
| 117 | —FUSION PHARMACEUTICALS INC | 1,227,017 | $5.1B | 78.96% | |
| 118 | PRTAPROTHENA CORP PLC | 100,000 | $4.9B | 76.23% | |
| 119 | —DA32 LIFE SCNCE TEC ACQSTN C | 500,000 | $4.9B | 75.69% | |
| 120 | DNAYCODEX DNA INC | 425,000 | $4.6B | 70.83% | |
| 121 | —HEALTH SCIENCES ACQ CORP 2 | 450,000 | $4.5B | 69.99% | |
| 122 | DRIOEURDARIOHEALTH CORP | 327,869 | $4.3B | 65.61% | |
| 123 | —NEPTUNE WELLNESS SOLUTIONS I | 10,055,521 | $4.1B | 63.62% | |
| 124 | RPIDRAPID MICRO BIOSYSTEMS INC | 385,693 | $4.1B | 63.33% | |
| 125 | —SONENDO INC | 668,505 | $3.9B | 59.42% | |
| 126 | 698ACHILLES THERAPEUTICS PLC | 755,375 | $3.8B | 58.39% | |
| 127 | AXSMAXSOME THERAPEUTICS INC | 80,420 | $3.0B | 46.88% | |
| 128 | PMVPPMV PHARMACEUTICALS INC | 125,000 | $2.9B | 44.56% | |
| 129 | TARAPROTARA THERAPEUTICS INC | 421,641 | $2.8B | 43.91% | |
| 130 | SRZNSURROZEN INC | 413,446 | $2.7B | 41.09% | |
| 131 | MNLOUSDVYNE THERAPEUTICS INC | 2,178,022 | $2.2B | 34.29% | |
| 132 | DCPHEURDECIPHERA PHARMACEUTICALS IN | 200,000 | $2.0B | 30.15% | Call |
| 133 | NVROEURNEVRO CORP | 22,946 | $1.9B | 28.70% | |
| 134 | RACEFERRARI N V | 6,200 | $1.6B | 24.77% | |
| 135 | 5E7ITEOS THERAPEUTICS INC | 20,000 | $931.0M | 14.37% | |
| 136 | —MOTUS GI HLDGS INC | 1,800,542 | $841.0M | 12.98% | |
| 137 | CLDNEUREIGER BIOPHARMACEUTICALS INC | 139,890 | $726.0M | 11.20% | |
| 138 | —ROCKLEY PHOTONICS HOLDINGS L | 500,000 | $605.0M | 9.34% | |
| 139 | —MINERVA SURGICAL INC | 87,768 | $451.0M | 6.96% | |
| 140 | PHVSPHARVARIS N V | 27,000 | $389.0M | 6.00% | |
| 141 | —SOMALOGIC INC | 110,000 | $367.0M | 5.66% | |
| 142 | BFLYWBUTTERFLY NETWORK INC | 233,333 | $296.0M | 4.57% | |
| 143 | —EQRX INC | 250,000 | $266.0M | 4.10% | |
| 144 | SRZNWSURROZEN INC | 166,666 | $192.0M | 2.96% | |
| 145 | —CAREMAX INC | 60,000 | $84.0M | 1.30% |
PreviousPage 2 of 2